Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 54,343 | 51,661 | 55,664 | 55,596 | 53,203 |
| Operating Income | -54,343 | -51,661 | -55,664 | -55,596 | -53,203 |
| Interest Expense | 3,467 | 4,937 | 4,889 | 4,834 | 4,780 |
| Other Income | 25 | 314 | 306 | 598 | 342 |
| Pre-tax Income | -57,785 | -56,284 | -60,247 | -59,832 | -57,641 |
| Net Income Continuous | -57,785 | -56,284 | -60,247 | -59,832 | -57,641 |
| Net Income | $-57,785 | $-56,284 | $-60,247 | $-59,832 | $-57,641 |
| EPS Basic Total Ops | -0.76 | -0.75 | -0.80 | -0.80 | -0.78 |
| EPS Basic Continuous Ops | -0.76 | -0.74 | -0.80 | -0.80 | -0.78 |
| EPS Diluted Total Ops | -0.76 | -0.75 | -0.80 | -0.80 | -0.78 |
| EPS Diluted Continuous Ops | -0.76 | -0.74 | -0.80 | -0.80 | -0.78 |
| EBITDA(a) | $-52,829 | $-48,478 | $-52,580 | $-52,571 | $-50,258 |